8-K current report · filed Oct 21, 2026

Thermo Fisher Scientific (TMO) 8-K Current Report: October 21, 2026

Item 2.02Item EX-99.1TMO overview

Short answer

Thermo Fisher Scientific (TMO) filed an 8-K current report with the SEC on October 21, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Q3 fiscal 2026 results announced October 21, 2026.

Thermo Fisher Scientific 8-K event analysis

AI summary of each reported item and its exhibits

Item 2.02 · Results of Operations and Financial Condition

  • Q3 fiscal 2026 results announced October 21, 2026
  • Reporting period ended September 26, 2026
  • Full earnings release furnished as Exhibit 99.1, containing the substantive financial details

Item EX-99.1 · Exhibit EX-99.1

  • Q3 revenue $12.14B, up 9%, with 6% organic growth, indicating broad underlying demand beyond acquisitions and divestitures
  • GAAP diluted EPS $4.64, up 9%; adjusted EPS $6.68, up 15%, showing stronger earnings growth after acquisition-related adjustments
  • GAAP operating margin 18.6% vs 17.4%; adjusted margin 24.5% vs 23.3%, reflecting operating leverage and execution
  • Nine-month free cash flow $4.62B vs $3.32B, supporting acquisitions, debt management, buybacks and dividends
  • Q3 capital deployment included microbiology divestiture completion; nine-month acquisitions totaled $8.88B and share repurchases $4.00B

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Thermo Fisher Scientific 8-K filings

Get the next TMO 8-K as it lands

Follow TMO for push alerts, or ask the research agent what this filing means.